(Q36284086)

13 August 2017

1 reference

title

Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency (English)

1 reference

13 August 2017

Stan Gee Louie

1

1 reference

13 August 2017

David Alexander Sclar

series ordinal

2

1 reference

13 August 2017

Mark Anthony Gill

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

11 October 2005

1 reference

Annals of Pharmacotherapy

13 August 2017

published in

1 reference

13 August 2017

volume

39

1 reference

13 August 2017

issue

11

1 reference

13 August 2017

page(s)

1861-1869

1 reference

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

13 August 2017

cites work

1 reference

Elastin gene expression is upregulated during pulmonary fibrosis

21 January 2018

1 reference

Molecular basis of alpha-1-antitrypsin deficiency

21 January 2018

1 reference

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema

21 January 2018

1 reference

Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects

21 January 2018

1 reference

Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.

21 January 2018

1 reference

Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys

21 January 2018

1 reference

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy

21 January 2018

1 reference

Complete sequence of the cDNA for human .alpha.1-antitrypsin and the gene for the S variant

21 January 2018

1 reference

The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency

21 January 2018

1 reference

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

21 January 2018

1 reference

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

21 January 2018

1 reference

Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience

21 January 2018

1 reference

Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.

21 January 2018

1 reference

Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis

21 January 2018

1 reference

Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E061

1 reference

13 August 2017

1 reference